NOBELACTIVE: payments to doctors
Payments that named NOBELACTIVE as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.5M
- Providers
- 24,121
- Transactions
- 60,999
- Average per transaction
- $90
The per-transaction average — $90 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 24,121 providers the average total is $228, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Nobel Biocare USA | $5,477,019 | 99.5% |
| Kerr Corporation | $8,956 | 0.2% |
| Ormco Corporation | $6,632 | 0.1% |
| Envista Holdings Corporation | $6,096 | 0.1% |
| Dental Imaging Technologies Corp. | $2,427 | 0.0% |
| Implant Direct Sybron International LLC | $1,365 | 0.0% |